Skip to content

Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population

Clinical Evaluation of DAILIES TOTAL 1® Multifocal Compared to 1-Day Acuvue® Moist® Multifocal in a Japanese Population

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03341923
Enrollment
151
Registered
2017-11-14
Start date
2017-12-20
Completion date
2018-06-05
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia, Refractive Error

Keywords

contact lenses, lens centration, multifocal

Brief summary

The purpose of this clinical study is to evaluate DAILIES TOTAL1® Multifocal (DT1MF) contact lenses compared to 1-DAY ACUVUE® Moist® Multifocal (AMMF) contact lenses for investigator-graded lens centration in a Japanese population.

Detailed description

Subjects will be randomly assigned to one of two sequences of investigational product wear ((DT1MF→AMMF, AMMF→DT1MF). Each product will be worn in both eyes for at least 11 days.

Interventions

Silicone hydrogel multifocal contact lenses for daily disposable wear

DEVICEEtafilcon A multifocal contact lenses

Hydrogel multifocal contact lenses for daily disposable wear

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Sign informed consent * Habitually wear multifocal soft/ silicone hydrogel contact lenses * Require a near spectacle ADD of +0.50 diopters (D) to +2.50D (inclusive) * Correctable to 20/30 Snellen or 0.2 logarithm minimum angle of resolution (logMAR) or better in each eye at distance * Willing to wear contact lenses and attend all study visits

Exclusion criteria

* Currently wearing DAILIES TOTAL 1® Multifocal or 1-DAY ACUVUE® Moist® Multifocal contact lenses * Any eye condition that would make contact lens wear unadvisable * Any use of medication that would make contact lens wear unadvisable * Prior refractive surgery

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Subjects With Investigator-graded Lens Centration of OptimalDay 14, each productLens centration was assessed by slit-lamp microscopy and graded on a 5-point scale, where 0=Optimal/Centered and 4=Severe decentration (with corneal exposure). One target eye was randomly selected for analysis.

Countries

Japan

Participant flow

Recruitment details

Subjects were recruited from 4 study sites located in Japan.

Pre-assignment details

Of the 151 enrolled, 17 subjects were exited as screen failures prior to randomization. This reporting group includes all randomized subjects (134).

Participants by arm

ArmCount
Overall
Delefilcon A multifocal contact lenses and etafilcon A multifocal contact lenses worn during Period 1 and Period 2 in a crossover assignment, as randomized.
134
Total134

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 2, Second 14 Days of WearAdverse Event01

Baseline characteristics

CharacteristicOverall
Age, Continuous53.1 years
STANDARD_DEVIATION 5.1
Race/Ethnicity, Customized
Japanese
134 Participants
Sex: Female, Male
Female
103 Participants
Sex: Female, Male
Male
31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 2660 / 1330 / 2680 / 134
other
Total, other adverse events
88 / 2660 / 13382 / 2680 / 134
serious
Total, serious adverse events
0 / 2660 / 1330 / 2680 / 134

Outcome results

Primary

Percentage of Subjects With Investigator-graded Lens Centration of Optimal

Lens centration was assessed by slit-lamp microscopy and graded on a 5-point scale, where 0=Optimal/Centered and 4=Severe decentration (with corneal exposure). One target eye was randomly selected for analysis.

Time frame: Day 14, each product

Population: Full Analysis Set with data available

ArmMeasureValue (NUMBER)
DT1MFPercentage of Subjects With Investigator-graded Lens Centration of Optimal97.0 percentage of subjects
AMMFPercentage of Subjects With Investigator-graded Lens Centration of Optimal91.0 percentage of subjects
p-value: 0.045595% CI: [0.2, 11.9]McNemar
p-value: 0.045595% CI: [0.2, 11.9]McNemar

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026